Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 163.68 million as of May 13, 2025. Its market cap has increased by 25.50% in one year.

Market Cap

163.68M

Enterprise Value

201.81M

Revenue

48.21M

Ranking

n/a

PE Ratio

11.35

Stock Price

8.32

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 163.68M, a decrease of -47.04%. That is a compound annual growth rate of -3.39%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	163.68M	-6.02%
Dec 30, 2024	174.16M	97.16%
Dec 29, 2023	88.33M	219.35%
Dec 30, 2022	27.66M	-4.32%
Dec 30, 2021	28.91M	-24.65%
Dec 30, 2020	38.37M	-66.14%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Roche Holding AG	209.97B
Novartis AG	178.12B
Lonza Group AG	40.67B
Alcon	39.60B
Galderma Group AG	23.81B
Straumann Holding AG	17.82B
Sandoz Group AG	16.28B
Sonova Holding AG	15.87B

Market Cap Rankings